|Videos|April 22, 2022
Q&A: Oligonucleotide Synthesis in Process Development and Scale-Up
Author(s)Cytiva
Give a quick overview of the oligonucleotide market, what is happening. Cover the typical challenges with oligonucleotide synthesis in the process development phase and solutions for those. Key considerations when scaling up oligonucleotide synthesis
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
4
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
5
